Cancer and Metastasis Reviews

, Volume 25, Issue 2, pp 243–252

Inhibitors of growth factor receptors, signaling pathways and angiogenesis as therapeutic molecular agents

  • Jocelyn Holash
  • Gavin Thurston
  • John S. Rudge
  • George D. Yancopoulos
  • Alex A. Adjei
  • Gabriele Bergers
  • Bronislaw Pytowski
  • Mark Pegram
  • Michael S. Gordon
Article

DOI: 10.1007/s10555-006-8504-6

Cite this article as:
Holash, J., Thurston, G., Rudge, J.S. et al. Cancer Metastasis Rev (2006) 25: 243. doi:10.1007/s10555-006-8504-6

Copyright information

© Springer Science + Business Media, LLC 2006

Authors and Affiliations

  • Jocelyn Holash
    • 1
  • Gavin Thurston
    • 1
  • John S. Rudge
    • 1
  • George D. Yancopoulos
    • 1
  • Alex A. Adjei
    • 2
  • Gabriele Bergers
    • 3
  • Bronislaw Pytowski
    • 4
  • Mark Pegram
    • 5
  • Michael S. Gordon
    • 6
  1. 1.Regeneron PharmaceuticalsTarrytownUSA
  2. 2.Mayo Clinic FoundationRochesterUSA
  3. 3.Department of Neurological Surgery, Brain Tumor Research Center and UCSF Comprehensive Cancer CenterUniversity of CaliforniaSan FranciscoUSA
  4. 4.ImClone SystemsNew YorkUSA
  5. 5.Department of Medical OncologyUCLALos AngelesUSA
  6. 6.Premiere Oncology of ArizonaScottsdaleUSA

Personalised recommendations